Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Sep 21, 2024; 30(35): 3932-3941
Published online Sep 21, 2024. doi: 10.3748/wjg.v30.i35.3932
Published online Sep 21, 2024. doi: 10.3748/wjg.v30.i35.3932
Advances in understanding and managing celiac disease: Pathophysiology and treatment strategies
Hao-Jie Ge, Xu-Lin Chen, Department of Burns, The First Affiliated Hospital of Anhui Medical University, Hefei 230022, Anhui Province, China
Author contributions: Ge HJ wrote the original draft, prepared the figure, and revised the manuscript; Chen XL conducted conceptualization and supervision.
Conflict-of-interest statement: The authors declare no conflict of interest for this article.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Xu-Lin Chen, MD, Director, Doctor, Department of Burns, The First Affiliated Hospital of Anhui Medical University, No. 218 Jixi Road, Hefei 230022, Anhui Province, China. okcxl@126.com
Received: March 6, 2024
Revised: August 12, 2024
Accepted: August 26, 2024
Published online: September 21, 2024
Processing time: 190 Days and 10.6 Hours
Revised: August 12, 2024
Accepted: August 26, 2024
Published online: September 21, 2024
Processing time: 190 Days and 10.6 Hours
Core Tip
Core Tip: This editorial provides a comprehensive review of the pathophysiological mechanisms underlying celiac disease and explores emerging therapeutic strategies, including the potential role of Aspergillus niger-derived prolyl endopeptidase. The discussion emphasizes the need for new treatments that address the multifaceted nature of the disease, aiming to improve patient quality of life beyond the limitations of a strict gluten-free diet.